When I first learned about pharmacovigilance during my pharmacy studies, I thought it was mainly about collecting adverse drug reaction (ADR) reports. It seemed like a process filled with forms, databases, and documentation. However, after gaining exposure through my Pharmacovigilance internship and later working as a Medical Information Associate, I realized that pharmacovigilance is much more than reporting, it is about protecting patients by continuously monitoring the safety of medicines.
One thing that completely changed my perspective was understanding that every ADR report has value. Many people assume that only serious or rare adverse reactions should be reported. In reality, even a single well-documented report can contribute to identifying a new safety signal when combined with similar reports from different healthcare professionals and countries. What appears to be an isolated event today could become an important finding tomorrow.
My experience also helped me understand how closely pharmacovigilance and medical information are connected. Healthcare professionals frequently seek evidence based information about the safety of medicines, adverse effects, and their management. Responding to these queries requires reviewing scientific literature, understanding available safety data, and communicating information accurately. This taught me that patient safety depends not only on collecting data but also on interpreting and sharing reliable evidence.
Another important lesson I learned is that pharmacovigilance is not about proving that a medicine is unsafe. Every medicine has both benefits and risks. The purpose of pharmacovigilance is to continuously evaluate these risks throughout a medicine’s life cycle so that healthcare professionals and patients can make informed decisions.
As future pharmacists, we have an important role to play. Encouraging ADR reporting, documenting complete and accurate information, and spreading awareness about pharmacovigilance can strengthen the healthcare system. Even a report that seems insignificant may contribute to improving the safety profile of a medicine and protecting countless patients in the future.
Pharmacovigilance is more than a regulatory requirement, it is a commitment to patient safety. Every report represents a real patient, and every contribution has the potential to make medicine use safer for people around the world.
What do you think is the biggest reason for underreporting of adverse drug reactions? Share your thoughts and experiences in the comments.